Buscar
01/01/2024
New molecular tools for precision medicine in pituitary neuroendocrine tumors
Marques-Pamies, M, Gil, J, Valassi, E, Pons, L, Carrato, C, Jordà, M, Puig-Domingo, M. New molecular tools for precision medicine in pituitary neuroendocrine tumors. Minerva Endocrinology. 2024; 49(3)DOI:10.23736/S2724-6507.23.04063-0. PMID:38261299. IF:1.900(Q3/8D).
01/12/2023
Predictors of Response to Treatment with First-Generation Somatostatin Receptor Ligands in Patients with Acromegaly
Marques-Pamies, M, Gil, J, Jordà, M, Puig-Domingo, M. Predictors of Response to Treatment with First-Generation Somatostatin Receptor Ligands in Patients with Acromegaly. ARCHIVES OF MEDICAL RESEARCH. 2023; 54(8)DOI:10.1016/j.arcmed.2023.102924. PMID:38042683. IF:4.700(Q1/3D).
31/10/2023
Revisiting the usefulness of the short acute octreotide test to predict treatment outcomes in acromegaly
Marques-Pamies, M, Gil, J, Valassi, E, Hernández, M, Biagetti, B, Giménez-Palop, O, Martínez, S, Carrato, C, Pons, L, Villar-Taibo, R, Araujo-Castro, M, Blanco, C, Simón, I, Simó-Servat, A, Xifra, G, Vázquez, F, Pavón, I, García-Centeno, R, Zavala, R, Hanzu, FA, Mora, M, Aulinas, A, Vilarrasa, N, Librizzi, S, Calatayud, M, de Miguel, P, Alvarez-Escola, C, Picó, A, Sampedro, M, Salinas, I, Fajardo-Montañana, C, Cámara, R, Bernabéu, I, Jordà, M, Webb, SM, Marazuela, M, Puig-Domingo, M. Revisiting the usefulness of the short acute octreotide test to predict treatment outcomes in acromegaly. Frontiers in Endocrinology. 2023; 14DOI:10.3389/fendo.2023.1269787. PMID:38027102. IF:3.900(Q2/3D).
02/08/2023
Oxytocin response to food intake in avoidant/restrictive food intake disorder
Aulinas, A, Muhammed, M, Becker, KR, Asanza, E, Hauser, K, Stern, C, Gydus, J, Holmes, T, Murray, HB, Breithaupt, L, Micali, N, Misra, M, Eddy, KT, Thomas, JJ, Lawson, EA. Oxytocin response to food intake in avoidant/restrictive food intake disorder. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2023; 189(2)DOI:10.1093/ejendo/lvad087. PMID:37474111. IF:5.300(Q1/2D).